vs

Side-by-side financial comparison of Agilent Technologies (A) and Ryerson Holding Corp (RYI). Click either name above to swap in a different company.

Agilent Technologies is the larger business by last-quarter revenue ($1.8B vs $1.1B, roughly 1.6× Ryerson Holding Corp). Agilent Technologies runs the higher net margin — 17.0% vs -3.4%, a 20.4% gap on every dollar of revenue. On growth, Ryerson Holding Corp posted the faster year-over-year revenue change (9.7% vs 7.0%). Agilent Technologies produced more free cash flow last quarter ($175.0M vs $91.9M). Over the past eight quarters, Agilent Technologies's revenue compounded faster (6.9% CAGR vs -5.6%).

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...

Joseph T. Ryerson & Son, Inc. is a services company that processes and distributes metals, with operations in the United States, Mexico, Canada, and China. Founded in 1842, Ryerson is headquartered in Chicago and employs approximately 4,200 employees at about 100 locations.

A vs RYI — Head-to-Head

Bigger by revenue
A
A
1.6× larger
A
$1.8B
$1.1B
RYI
Growing faster (revenue YoY)
RYI
RYI
+2.7% gap
RYI
9.7%
7.0%
A
Higher net margin
A
A
20.4% more per $
A
17.0%
-3.4%
RYI
More free cash flow
A
A
$83.1M more FCF
A
$175.0M
$91.9M
RYI
Faster 2-yr revenue CAGR
A
A
Annualised
A
6.9%
-5.6%
RYI

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
A
A
RYI
RYI
Revenue
$1.8B
$1.1B
Net Profit
$305.0M
$-37.9M
Gross Margin
52.6%
15.3%
Operating Margin
19.6%
-3.4%
Net Margin
17.0%
-3.4%
Revenue YoY
7.0%
9.7%
Net Profit YoY
-4.1%
-781.4%
EPS (diluted)
$1.07
$-1.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
A
A
RYI
RYI
Q1 26
$1.8B
Q4 25
$1.9B
$1.1B
Q3 25
$1.7B
$1.2B
Q2 25
$1.7B
$1.2B
Q1 25
$1.7B
$1.1B
Q4 24
$1.7B
$1.0B
Q3 24
$1.6B
$1.1B
Q2 24
$1.6B
$1.2B
Net Profit
A
A
RYI
RYI
Q1 26
$305.0M
Q4 25
$434.0M
$-37.9M
Q3 25
$336.0M
$-14.8M
Q2 25
$215.0M
$1.9M
Q1 25
$318.0M
$-5.6M
Q4 24
$351.0M
$-4.3M
Q3 24
$282.0M
$-6.6M
Q2 24
$308.0M
$9.9M
Gross Margin
A
A
RYI
RYI
Q1 26
52.6%
Q4 25
53.2%
15.3%
Q3 25
51.1%
17.2%
Q2 25
51.9%
17.9%
Q1 25
53.5%
18.0%
Q4 24
53.9%
19.0%
Q3 24
54.2%
17.9%
Q2 24
54.4%
18.2%
Operating Margin
A
A
RYI
RYI
Q1 26
19.6%
Q4 25
23.8%
-3.4%
Q3 25
20.7%
-0.1%
Q2 25
18.0%
0.5%
Q1 25
22.4%
0.2%
Q4 24
24.0%
0.3%
Q3 24
21.1%
0.5%
Q2 24
23.1%
1.9%
Net Margin
A
A
RYI
RYI
Q1 26
17.0%
Q4 25
23.3%
-3.4%
Q3 25
19.3%
-1.3%
Q2 25
12.9%
0.2%
Q1 25
18.9%
-0.5%
Q4 24
20.6%
-0.4%
Q3 24
17.9%
-0.6%
Q2 24
19.6%
0.8%
EPS (diluted)
A
A
RYI
RYI
Q1 26
$1.07
Q4 25
$1.53
$-1.18
Q3 25
$1.18
$-0.46
Q2 25
$0.75
$0.06
Q1 25
$1.11
$-0.18
Q4 24
$1.23
$-0.13
Q3 24
$0.97
$-0.20
Q2 24
$1.05
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
A
A
RYI
RYI
Cash + ST InvestmentsLiquidity on hand
$1.8B
$26.9M
Total DebtLower is stronger
$3.0B
Stockholders' EquityBook value
$6.9B
$753.1M
Total Assets
$12.8B
$2.4B
Debt / EquityLower = less leverage
0.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
A
A
RYI
RYI
Q1 26
$1.8B
Q4 25
$1.8B
$26.9M
Q3 25
$1.5B
$29.8M
Q2 25
$1.5B
$30.8M
Q1 25
$1.5B
$33.6M
Q4 24
$1.3B
$27.7M
Q3 24
$1.8B
$35.0M
Q2 24
$1.7B
$28.0M
Total Debt
A
A
RYI
RYI
Q1 26
$3.0B
Q4 25
$3.0B
Q3 25
$3.4B
Q2 25
$3.3B
Q1 25
$3.3B
Q4 24
$3.3B
Q3 24
$2.1B
Q2 24
$2.1B
Stockholders' Equity
A
A
RYI
RYI
Q1 26
$6.9B
Q4 25
$6.7B
$753.1M
Q3 25
$6.4B
$787.3M
Q2 25
$6.1B
$811.5M
Q1 25
$6.0B
$803.9M
Q4 24
$5.9B
$815.3M
Q3 24
$5.9B
$832.9M
Q2 24
$6.2B
$877.9M
Total Assets
A
A
RYI
RYI
Q1 26
$12.8B
Q4 25
$12.7B
$2.4B
Q3 25
$12.2B
$2.5B
Q2 25
$12.2B
$2.5B
Q1 25
$11.9B
$2.5B
Q4 24
$11.8B
$2.4B
Q3 24
$11.0B
$2.5B
Q2 24
$10.9B
$2.6B
Debt / Equity
A
A
RYI
RYI
Q1 26
0.44×
Q4 25
0.45×
Q3 25
0.53×
Q2 25
0.55×
Q1 25
0.56×
Q4 24
0.57×
Q3 24
0.36×
Q2 24
0.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
A
A
RYI
RYI
Operating Cash FlowLast quarter
$268.0M
$112.7M
Free Cash FlowOCF − Capex
$175.0M
$91.9M
FCF MarginFCF / Revenue
9.7%
8.3%
Capex IntensityCapex / Revenue
5.2%
1.9%
Cash ConversionOCF / Net Profit
0.88×
TTM Free Cash FlowTrailing 4 quarters
$993.0M
$35.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
A
A
RYI
RYI
Q1 26
$268.0M
Q4 25
$545.0M
$112.7M
Q3 25
$362.0M
$-8.3M
Q2 25
$221.0M
$23.8M
Q1 25
$431.0M
$-41.2M
Q4 24
$481.0M
$92.2M
Q3 24
$452.0M
$134.6M
Q2 24
$333.0M
$25.9M
Free Cash Flow
A
A
RYI
RYI
Q1 26
$175.0M
Q4 25
$452.0M
$91.9M
Q3 25
$259.0M
$-21.1M
Q2 25
$107.0M
$13.9M
Q1 25
$334.0M
$-49.2M
Q4 24
$388.0M
$68.7M
Q3 24
$360.0M
$103.0M
Q2 24
$230.0M
$3.2M
FCF Margin
A
A
RYI
RYI
Q1 26
9.7%
Q4 25
24.3%
8.3%
Q3 25
14.9%
-1.8%
Q2 25
6.4%
1.2%
Q1 25
19.9%
-4.3%
Q4 24
22.8%
6.8%
Q3 24
22.8%
9.1%
Q2 24
14.6%
0.3%
Capex Intensity
A
A
RYI
RYI
Q1 26
5.2%
Q4 25
5.0%
1.9%
Q3 25
5.9%
1.1%
Q2 25
6.8%
0.8%
Q1 25
5.8%
0.7%
Q4 24
5.5%
2.3%
Q3 24
5.8%
2.8%
Q2 24
6.5%
1.9%
Cash Conversion
A
A
RYI
RYI
Q1 26
0.88×
Q4 25
1.26×
Q3 25
1.08×
Q2 25
1.03×
12.53×
Q1 25
1.36×
Q4 24
1.37×
Q3 24
1.60×
Q2 24
1.08×
2.62×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

A
A

Service Other$525.0M29%
Chemicaland Energy Market$422.0M23%
Agilent Cross Lab$273.0M15%
Environmentaland Forensics Market$177.0M10%
Food Market$166.0M9%
Academiaand Government Market$130.0M7%
Applied Markets$98.0M5%

RYI
RYI

US$988.3M89%
Non Us$116.5M11%

Related Comparisons